Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: A basis for tumor-promoting interactions

Cytokine

Volumn 44, Issue 1, 2008, Pages 191-200

  Soria, Gali ^a   Yaal Hahoshen, Neora ^b   Azenshtein, Elina ^a   Shina, Sima ^a   Leider Trejo, Leonor ^b   Ryvo, Larisa ^b   Cohen Hillel, Efrat ^a   Shtabsky, Alex ^b   Ehrlich, Marcelo ^a   Meshel, Tsipi ^a   Keydar, Iafa ^a   Ben Baruch, Adit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Ductal Carcinoma In Situ; Invasive Ductal Carcinoma; MCP 1; RANTES

Indexed keywords

CALCIUM; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ARTICLE; BREAST CANCER; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CYTOKINE RELEASE; EXOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; TUMOR CELL; TUMOR PROMOTION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINE, TUMOR; CHEMOKINE CCL2; CHEMOKINE CCL5; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; PLEURAL EFFUSION;

EID: 52949094598     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.08.002     Document Type: Article

References (63)

1. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25 (2006) 357-371
2. Conti I., and Rollins B.J. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 14 (2004) 149-154
3. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13 (2006) 191-199
4. Strieter R.M., Burdick M.D., Mestas J., Gomperts B., Keane M.P., and Belperio J.A. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42 (2006) 768-778
5. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
6. Lavergne E., Combadiere C., Iga M., Boissonnas A., Bonduelle O., Maho M., et al. Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Immunol 173 (2004) 3755-3762
7. Huang S., Singh R.K., Xie K., Gutman M., Berry K.K., Bucana C.D., et al. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother 39 (1994) 231-238
8. Soria G., and Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267 (2008) 271-285
9. Ueno T., Toi M., Saji H., Muta M., Bando H., Kuroi K., et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6 (2000) 3282-3289
10. Luboshits G., Shina S., Kaplan O., Engelberg S., Nass D., Lifshitz-Mercer B., et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59 (1999) 4681-4687
11. Niwa Y., Akamatsu H., Niwa H., Sumi H., Ozaki Y., and Abe A. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7 (2001) 285-289
12. Goede V., Brogelli L., Ziche M., and Augustin H.G. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82 (1999) 765-770
13. Saji H., Koike M., Yamori T., Saji S., Seiki M., Matsushima K., et al. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92 (2001) 1085-1091
14. Valkovic T., Lucin K., Krstulja M., Dobi-Babic R., and Jonjic N. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract 194 (1998) 335-340
15. Lebrecht A., Grimm C., Lantzsch T., Ludwig E., Hefler L., Ulbrich E., et al. Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol 25 (2004) 14-17
16. Bieche I., Lerebours F., Tozlu S., Espie M., Marty M., and Lidereau R. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 10 (2004) 6789-6795
17. Nouh M.A., Eissa S.A., Zaki S.A., El-Maghraby S.M., and Kadry D.Y. Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst 17 (2005) 51-55
18. Dehqanzada Z.A., Storrer C.E., Hueman M.T., Foley R.J., Harris K.A., Jama Y.H., et al. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep 17 (2007) 687-694
19. Ghilardi G., Biondi M.L., La Torre A., Battaglioli L., and Scorza R. Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1)-2518 G allele. Clin Chem 51 (2005) 452-455
20. Zafiropoulos A., Crikas N., Passam A.M., and Spandidos D.A. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41 (2004) e59
21. Yaal-Hahoshen N., Shina S., Leider-Trejo L., Barnea I., Shabtai E.L., Azenshtein E., et al. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res 12 (2006) 4474-4480
22. Nam J.S., Kang M.J., Suchar A.M., Shimamura T., Kohn E.A., Michalowska A.M., et al. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 66 (2006) 7176-7184
23. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96 (2000) 34-40
24. Adler E.P., Lemken C.A., Katchen N.S., and Kurt R.A. A dual role for tumor-derived chemokine RANTES (CCL5). Immunol Lett 90 (2003) 187-194
25. Stormes K.A., Lemken C.A., Lepre J.V., Marinucci M.N., and Kurt R.A. Inhibition of metastasis by inhibition of tumor-derived CCL5. Breast Cancer Res Treat 89 (2005) 209-212
26. Jayasinghe MM, Golden JM, Nair P, O'Donnell CM, Werner MT, Kurt RA. Tumor-derived CCL5 does not contribute to breast cancer progression. Breast Cancer Res Treat 2007.
27. Robinson S.C., Scott K.A., Wilson J.L., Thompson R.G., Proudfoot A.E., and Balkwill F.R. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 63 (2003) 8360-8365
28. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
29. Yamashiro S., Takeya M., Nishi T., Kuratsu J., Yoshimura T., Ushio Y., et al. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol 145 (1994) 856-867
30. Dupre S.A., Redelman D., and Hunter Jr. K.W. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int J Exp Pathol 88 (2007) 351-360
31. Valkovic T., Fuckar D., Stifter S., Matusan K., Hasan M., Dobrila F., et al. Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma. J Cancer Res Clin Oncol 131 (2005) 453-458
32. Kurt R.A., Baher A., Wisner K.P., Tackitt S., and Urba W.J. Chemokine receptor desensitization in tumor-bearing mice. Cell Immunol 207 (2001) 81-88
33. Vitiello P.F., Shainheit M.G., Allison E.M., Adler E.P., and Kurt R.A. Impact of tumor-derived CCL2 on T cell effector function. Immunol Lett 91 (2004) 239-245
34. Azenshtein E., Luboshits G., Shina S., Neumark E., Shahbazian D., Weil M., et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 62 (2002) 1093-1102
35. Condeelis J., and Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 (2006) 263-266
36. Lin E.Y., and Pollard J.W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67 (2007) 5064-5066
37. Bingle L., Lewis C.E., Corke K.P., Reed M.W., and Brown N.J. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94 (2006) 101-107
38. Yamada M., Kim S., Egashira K., Takeya M., Ikeda T., Mimura O., et al. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 23 (2003) 1996-2001
39. Weber K.S., Nelson P.J., Grone H.J., and Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19 (1999) 2085-2093
40. Hong K.H., Ryu J., and Han K.H. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105 (2005) 1405-1407
41. Azenshtein E., Meshel T., Shina S., Barak N., Keydar I., and Ben-Baruch A. The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett 217 (2005) 73-86
42. Youngs S.J., Ali S.A., Taub D.D., and Rees R.C. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71 (1997) 257-266
43. Prest S.J., Rees R.C., Murdoch C., Marshall J.F., Cooper P.A., Bibby M., et al. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin Exp Metastasis 17 (1999) 389-396
44. Cappellen D., Schlange T., Bauer M., Maurer F., and Hynes N.E. Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep 8 (2007) 70-76
45. Mira E., Lacalle R.A., Gonzalez M.A., Gomez-Mouton C., Abad J.L., Bernad A., et al. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep 2 (2001) 151-156
46. Mestdagt M., Polette M., Buttice G., Noel A., Ueda A., Foidart J.M., et al. Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells. Int J Cancer 118 (2006) 35-42
47. Kinder M., Chislock E., Bussard K.M., Shuman L., and Mastro A.M. Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res 314 (2008) 173-183
48. Zhu J., Jia X., Xiao G., Kang Y., Partridge N.C., and Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem 282 (2007) 26656-26664
49. Feniger-Barish R., Yron I., Meshel T., Matityahu E., and Ben-Baruch A. IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase. Biochemistry 42 (2003) 2874-2886
50. Page D.L. Breast lesions, pathology and cancer risk. Breast J 10 Suppl. 1 (2004) S3-4
51. Cuzick J. Treatment of DCIS-results from clinical trials. Surg Oncol 12 (2003) 213-219
52. Leonard G.D., and Swain S.M. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96 (2004) 906-920
53. Aronica S.M., Fanti P., Kaminskaya K., Gibbs K., Raiber L., Nazareth M., et al. Estrogen disrupts chemokine-mediated chemokine release from mammary cells: implications for the interplay between estrogen and IP-10 in the regulation of mammary tumor formation. Breast Cancer Res Treat 84 (2004) 235-245
54. Kawada K., Sonoshita M., Sakashita H., Takabayashi A., Yamaoka Y., Manabe T., et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 64 (2004) 4010-4017
55. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
56. Goldberg-Bittman E., Neumark E., Sagi-Assif O., Azenshtein E., Meshel T., Witz I.P., et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett 92 (2004) 171-178
57. Burgoyne R.D., and Morgan A. Secretory granule exocytosis. Physiol Rev 83 (2003) 581-632
58. Silzle T., Kreutz M., Dobler M.A., Brockhoff G., Knuechel R., and Kunz-Schughart L.A. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 33 (2003) 1311-1320
59. Inadera H., Sekiya T., Yoshimura T., and Matsushima K. Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology 141 (2000) 50-59
60. Kelly R.W., Carr G.G., and Riley S.C. The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone. Biochem Biophys Res Commun 239 (1997) 557-561
61. Neumark E., Sagi-Assif O., Shalmon B., Ben-Baruch A., and Witz I.P. Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors. Int J Cancer 106 (2003) 879-886
62. Ali S., Kaur J., and Patel K.D. Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am J Pathol 157 (2000) 313-321
63. Seeger H., Wallwiener D., and Mueck A.O. Different effects of estradiol and various antiestrogens on TNF-alpha-induced changes of biochemical markers for growth and invasion of human breast cancer cells. Life Sci 78 (2006) 1464-1468